Clinical trial
Multicenter Study of Fulminant Type 1 Diabetes in China
NCT05593081 is registered in ClinicalTrials.gov with Second Xiangya Hospital of Central South University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Study of Fulminant Type 1 Diabetes in China
- Lead sponsor
- Second Xiangya Hospital of Central South University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 20, 2022
- Completion date
- December 31, 2027
- Enrollment
- 240 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.